Researchers from Ben Gurion University and Soroka Medical Center developed Methylmevalonolactone to save sufferers of a rare deadly hereditary muscle disease. They are now testing it as a treatment for tens of thousands of sufferers of chronic muscle pain due to statins.
https://in.bgu.ac.il/en/pages/news/muscle_disease.aspx
https://www.pnas.org/doi/10.1073/pnas.2217831120
https://nocamels.com/2023/03/new-israeli-drug-combats-deadly-muscular-disease/